Drug-Resistance Biomarkers in Leishmania infantum through Nanopore-Based Detection of Aneuploidy and...
Drug-Resistance Biomarkers in Leishmania infantum through Nanopore-Based Detection of Aneuploidy and Gene Copy Number Variations with LeishGenApp
About this item
Full title
Author / Creator
Marina Carrasco Martin , Marti-Carreras, Joan , Marcel Gomez Ponce , Alcover, Maria Magdalena , Roura, Xavier , Ferrer, Lluis , Baneth, Gad , Bruno, Federica , Chicharro, Carmen , Cordeiro-Da-Silva, Anabela , Cristovao, Jose , Trentina Di Muccio , Maia, Carla , Moreno, Javier , Priego, Anabel , Roca-Gerones, Xavier , Santarem, Nuno , Anna Vila Soriano , Vitale, Fabrizio , Yasur-Landau, Daniel and Francino, Olga
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
The emergence of drug-resistant strains of Leishmania infantum, a parasite that infects dogs and humans, poses an increasing threat, underscoring the need for a One Health framework for adequate control. Aneuploidy and gene copy-number variation (CNV) are associated with resistance to first-line drugs. We analyzed aneuploidies, genome plasticity, and 15 CNVs as drug-resistance biomarkers in 35 L. infantum isolates from human and canine host across the Mediterranean by nanopore-only whole-genome sequencing and the automated diagnostic platform LeishGenApp. Results highlighted different levels of aneuploidy turnover among chromosomes and characterized the structural organization of resistance-associated genomic regions, emphasizing the role of genomic repeated sequences in the extended H-locus, METK and SMT locus. At least one genomic resistance biomarker was detected in 80% of the Mediterranean isolates, being the most prevalent to antimonials (50%) and allopurinol (50%) in canine isolates and to antimonials (61%) and paramomycin (38%) in human isolates. Monoresistance (50%) predominates in dogs, while resistance to two drugs is most common in human isolates (38%). Differences in genomic resistance biomarkers prevalence in our cohort underscore the importance of targeted drug policies to mitigate resistance dissemination. Our results provide an effective approach for detecting aneuploidies and CNVs as drug-resistance biomarkers in Leishmania parasites by nanopore-only whole-genome sequencing. This powerful tool is significant for monitoring resistant L. infantum strains, particularly in dogs, the primary reservoir, lessening resistance-related relapses, limiting resistant Leishmania transmission by sand flies, and shaping One Health strategies.Competing Interest StatementThe authors have declared no competing interest.Footnotes* https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA881045...
Alternative Titles
Full title
Drug-Resistance Biomarkers in Leishmania infantum through Nanopore-Based Detection of Aneuploidy and Gene Copy Number Variations with LeishGenApp
Authors, Artists and Contributors
Author / Creator
Marti-Carreras, Joan
Marcel Gomez Ponce
Alcover, Maria Magdalena
Roura, Xavier
Ferrer, Lluis
Baneth, Gad
Bruno, Federica
Chicharro, Carmen
Cordeiro-Da-Silva, Anabela
Cristovao, Jose
Trentina Di Muccio
Maia, Carla
Moreno, Javier
Priego, Anabel
Roca-Gerones, Xavier
Santarem, Nuno
Anna Vila Soriano
Vitale, Fabrizio
Yasur-Landau, Daniel
Francino, Olga
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3159711598
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3159711598
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/2025.01.23.634476
How to access this item
https://www.proquest.com/docview/3159711598?pq-origsite=primo&accountid=13902